{"id":3185,"date":"2021-11-16T08:40:20","date_gmt":"2021-11-16T07:40:20","guid":{"rendered":"https:\/\/cendoc.h12o.es\/blog\/?p=3185"},"modified":"2021-11-16T08:40:20","modified_gmt":"2021-11-16T07:40:20","slug":"tratamientos-inmunosupresores-ninos-y-covid-19","status":"publish","type":"post","link":"https:\/\/cendoc.h12o.es\/blog\/2021\/11\/16\/tratamientos-inmunosupresores-ninos-y-covid-19\/","title":{"rendered":"Tratamientos inmunosupresores, ni\u00f1os y COVID-19"},"content":{"rendered":"<p>La revista <em>Neurology. Neuroimmunology &amp; Neuroinflammation<\/em> ha publicado<img loading=\"lazy\" decoding=\"async\" class=\" wp-image-3871 alignright\" src=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=225&amp;h=153\" alt=\"logo12\" width=\"225\" height=\"153\" data-attachment-id=\"3871\" data-permalink=\"https:\/\/coronavirusbiblioh12o.wordpress.com\/2020\/05\/06\/7-mas-del-h12o\/logo12\/\" data-orig-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg\" data-orig-size=\"275,183\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"logo12\" data-image-description=\"\" data-image-caption=\"\" data-medium-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=275\" data-large-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=275\" \/> \u201c<a href=\"https:\/\/nn.neurology.org\/content\/9\/1\/e1101\">Impact of COVID-19 in immunosuppressed children with neuroimmunologic disorders<\/a>\u201d, trabajo en el que figura como autora Ana Camacho, del Servicio de Neurolog\u00eda del Hospital 12 de Octubre.<\/p>\n<p>El objetivo de este art\u00edculo es analizar si los ni\u00f1os que reciben terapias inmunosupresoras para enfermedades neuroinmunol\u00f3gicas son m\u00e1s susceptibles de infectarse por SARS-COV-2 y desarrollar formas m\u00e1s graves de COVID-19. \u00a0Se analizaron los datos de 133 ni\u00f1os (mediana de edad, 13 a\u00f1os) con o sin tratamiento inmunosupresor entre marzo de 2020 y marzo de 2021, considerando caracter\u00edsticas demogr\u00e1ficas y cl\u00ednicas, tratamiento inmunosupresor y COVID-19. El 52% recib\u00eda tratamiento inmunosupresor. En el 11% se sospech\u00f3 COVID-19, similar en pacientes con o sin tratamiento; tambi\u00e9n la frecuencia de reca\u00eddas fue similar en ni\u00f1os con o sin tratamiento. Los factores asociados con COVID-19 fueron cohabitar con alguna persona COVID-19 o niveles sangu\u00edneos bajos de vitamina D. En el 79% de los pacientes la consulta cl\u00ednica cambi\u00f3 de presencial a remota. En conclusi\u00f3n, en esta cohorte de ni\u00f1os, la frecuencia de COVID-19 fue baja y no se vio afectada por los tratamientos inmunosupresores.<\/p>\n<p><em>Equipo Biblioteca H12O<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La revista Neurology. Neuroimmunology &amp; Neuroinflammation ha publicado \u201cImpact of COVID-19 in immunosuppressed children with neuroimmunologic disorders\u201d, trabajo en el que figura como autora Ana Camacho, del Servicio de Neurolog\u00eda del Hospital 12 de Octubre. El objetivo de este art\u00edculo es analizar si los ni\u00f1os que reciben terapias inmunosupresoras para \u2026<\/p>\n<p class=\"continue-reading-button\"> <a class=\"continue-reading-link\" href=\"https:\/\/cendoc.h12o.es\/blog\/2021\/11\/16\/tratamientos-inmunosupresores-ninos-y-covid-19\/\">Continuar leyendo<i class=\"crycon-right-dir\"><\/i><\/a><\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false},"version":2}},"categories":[4,64,46],"tags":[],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p3G9TJ-Pn","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/3185"}],"collection":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/comments?post=3185"}],"version-history":[{"count":1,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/3185\/revisions"}],"predecessor-version":[{"id":3186,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/3185\/revisions\/3186"}],"wp:attachment":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/media?parent=3185"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/categories?post=3185"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/tags?post=3185"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}